Anaplastic large cell lymphoma: The shifting sands of diagnostic hematopathology

Modern Pathology

Volumn 14, Issue 3, 2001, Pages 219-228

  Jaffe, E S ^a  

^a Laboratory of Pathology   (United States)

Author keywords

Anaplastic large cell lymphoma; CD30; Cytogenetics; Immunohistochemistry; Oncogenes; T cell lymphoma; Tyrosine kinase

Indexed keywords

CD30 ANTIGEN; PROTEIN TYROSINE KINASE;

ANAPLASTIC CARCINOMA; ANTIGEN EXPRESSION; CANCER CLASSIFICATION; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 5; CLINICAL FEATURE; DISEASE ASSOCIATION; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; REVIEW;

ACTIVIN RECEPTORS; ADOLESCENT; ADULT; ANTIGENS, CD30; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; LYMPHOMA, LARGE-CELL, KI-1; PROTEIN-SERINE-THREONINE KINASES; TRANSLOCATION, GENETIC;

EID: 0035082616     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880289     Document Type: Review

References (84)

1. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
2. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma")
3. A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis
4. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
5. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1
6. Production of a monoclonal antibody specific for Hodgkin and Reed-Sternberg cells of Hodgkin's disease and a subset of normal lymphoid cells
7. Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly-detected small-cell population
8. A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts
9. Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30)
10. Acute infectious mononucleosis, CD30 (Ki-1) antigen expression and histologic correlations
11. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
12. Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma
13. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome
14. Updated Kiel classification for lymphomas
15. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy
16. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
17. Large-cell anaplastic lymphoma-specific translocation (t[2; 5] [p23;q35]) in Hodgkin's disease: Indication of a common pathogenesis?
18. Analysis of the t(2;5) (p23;q35) translocation by reverse trasnscription-polymerase chain reaction in CD30 + anaplastic large-cell lymphomas, in other non-Hodgkin's of T-cell phenotype, and in Hodgkin's disease
19. Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease
20. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions
21. CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy
22. Transformation of follicular lymphoma into CD30-large cell lymphoma with anaplastic cytologic features
23. CD30 Expression in non-Hodgkin's lymphoma
24. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry
25. ALK-positive lymphoma: A single disease with a broad spectrum of morphology
26. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements
27. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma
28. Post-thymic T-cell lymphomas
29. Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35)
30. Anaplastic large cell lymphoma: A distinct molecular pathologic entity: A reappraisal with special reference to p80(NPM/ALK) expression
31. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Kil+) with a high content of reactive histiocytes
32. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type
33. Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma
34. Anaplastic large cell malignant lymphoma with extensive eosinophilic or neutrophilic infiltration
35. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie house
36. Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma
37. TPM-ALK fusion genes and ALK expression in inflammatory myofibroblastic tumor
38. ALK and p80 expression in inflammatory myofibroblastic tumor (IMT)
39. Anaplastic large cell lymphoma (CD30+/Ki-1+): Results of a prospective clinicopathologic study of 69 cases
40. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas - A continuous spectrum of malignant disorders
41. World Health Organization classification of lymphomas: A work in progress
42. ALK + lymphoma: Clinico-pathological findings and outcome
43. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma
44. Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35)
45. Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types
46. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK
47. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
48. Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas
49. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype
50. Classification of T-cell and NK-cell neoplasms based on the REAL classification
51. Lymphomatoid papulosis associated with Ki-1-positive anaplastic large cell lymphoma. A report of two cases and a review of the literature
52. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment
53. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin
54. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
55. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum
56. The clinicopathological features of anaplastic large cell lymphomas expressing p80NPM/ALK
57. Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance
58. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma
59. CD30(Ki-1) antigen expression in a subset of gastric mucosal plasma cells and in a primary gastric plasmacytoma
60. Ki-1-positive large cell lymphomas, a heterogenous group of neoplasms. Morphologic, immunophenotypic, genotypic, and clinical features of 24 cases
61. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas: Diagnostic value in so-called malignant histiocytosis
62. Immunoglobulin and T. cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: Dissociation between phenotype and genotype
63. Genotypic analysis of large cell lymphomas which express the Ki-1 antigen
64. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules
65. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: Evidence for distinct cellular origin
66. Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies
67. Regressing atypical histiocytosis: A review and critical appraisal
68. Malignant histiocytosis and true histiocytic lymphomas
69. PG-M1: A new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule
70. Antibody BNH9 detects red blood cell-related antigens on anaplastic large cell (CD30+) lymphomas
71. Detection of differentially expressed genes in lymphomas using cDNA arrays: Identification of clusterin as a new diagnostic marker for Anaplastic Large Cell Lymphomas (ALCL)
72. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: A comparative study
73. Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma
74. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation
75. Demonstration of Epstein-Barr viral genomes by in situ hybridization in acquired immune deficiency syndrome-related high grade and anaplastic large cell CD30+ lymphomas
76. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma
77. TRK-Fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations
78. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 Cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)
79. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis
80. A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma
81. Major nucleolar proteins shuttle between nucleus and cytoplasm
82. Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease
83. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction